Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
HUGO Series 🌟
HUGO-GT™ (Humanized Genomic Ortholog)
HUGO-Ab™ (Humanized Genomic Ortholog for Antibody)
HUGO-Mab™ Fully Human Monoclonal Antibody Mouse
HUGO-Light™ Fully Human Common Light Chain Mouse
MouseAtlas Model Library
Flash Sales
Research Models
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
Cell Line Models
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
iPSC Cell Line Product Catalog
AAV Standard Product Catalog
Services
Preclinical Efficacy
Neuroscience
Blood Brain Barrier (BBB)
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Models
Human Immune System (HIS) Mouse Model
Metabolic & Cardiovascular Diseases
Anti-Obesity
Autoimmune & Inflammatory
Asthma
Genetically Engineered Animals
Knockout Mice
Transgenic Mice
Knockin Mice
Knockout Rats
Knockin Rats
Transgenic Rats
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Breeding & Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Modalities
Gene Therapy
AI-Powered AAV Discovery
Oligonucleotide Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell Cell Culture
About Us
Corporate Overview
Facility Overview
Animal Health & Welfare
Health Reports
Our Team
Our Partners
Careers
Contact Us
Login
HomeMouseAtlas
huIL5/huIL5RA Mouse
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

huIL5/huIL5RA Mouse

Product Name
huIL5/huIL5RA Mouse
Product ID
C002042
Strain Name
C57BL/6NCya-Il5tm1(hIL5)Il5ratm1(hIL5RA)/Cya
Backgroud
C57BL/6NCya
Status
Live Mouse
When using this mouse strain in a publication, please cite “huIL5/huIL5RA Mouse (Catalog C002042) were purchased from Cyagen.”
HUGO-GT Humanized ModelsImmune Target Humanized Mouse ModelsCytokine Gene Humanized Mouse Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
HUGO-GT Humanized ModelsImmune Target Humanized Mouse ModelsCytokine Gene Humanized Mouse Models

Basic Information

Related Resource

Basic Information
Gene Name
IL5 & IL5RA
Gene Alias
EDF, TRF, IL-5, IL5R, CD125, CDw125, HSIL5R3
NCBI ID
3567 (Human) & 3568 (Human)
Chromosome
Chr 5 (Human), Chr 3 (Human)
MGI ID
MGI:96557; MGI:96558
Datasheet
Click here to download >>

Strain Description

The huIL5/huIL5RA mouse is a dual-gene humanized model obtained by mating huIL5 mice (Catalog No.: C001813) with huIL5RA mice (Catalog No.: C002007). This model is applicable to the screening of human IgG antibody drug candidates, as well as the evaluation of pharmacology, pharmacodynamics, and pharmacokinetics. It serves as a valuable tool for advancing research in immunotherapies for allergic diseases and the mechanisms of Th2-type immune responses.

Strain Strategy

The huIL5/huIL5RA mice are a dual-gene humanized model obtained by mating huIL5 mice (Catalog No.: C001813) with huIL5RA mice (Catalog No.: C002007).
Figure 1. Gene editing strategy for huIL5 mice. The sequences from the start codon to the stop codon of the endogenous mouse Il5 gene were replaced with the sequences from the start codon to the stop codon of the human IL5 gene.
Figure 1. Gene editing strategy for huIL5 mice. The sequences from the start codon to the stop codon of the endogenous mouse Il5 gene were replaced with the sequences from the start codon to the stop codon of the human IL5 gene.
Figure 2. Gene editing strategy of huIL5RA mice.The mouse Il5ra endogenous extracellular domain was replaced with the human IL5RA extracellular domain. The murine transmembrane-cytoplasmic region was preserved.
Figure 2. Gene editing strategy of huIL5RA mice.The mouse Il5ra endogenous extracellular domain was replaced with the human IL5RA extracellular domain. The murine transmembrane-cytoplasmic region was preserved.

Application Area

Screening, development, and preclinical evaluation of IL5/IL5RA-targeted therapeutics;
Assessment of allergic diseases immunotherapy and research into immune system mechanisms;
Development and screening of IgG antibody drug candidates;
Pharmacological, pharmacodynamic, and pharmacokinetic studies of IgG antibody drugs.
Related Resource
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Models
HUGO-Ab™ (Humanized Genomic Ortholog for Antibody)HUGO-GT™ (Humanized Genomic Ortholog)MouseAtlas Model LibraryResearch Models
Services
NeuroscienceOphthalmologyOncologyMetabolic & Cardiovascular DiseasesAutoimmune & Inflammatory
About Us
Corporate OverviewFacility OverviewAnimal Health & WelfareHealth ReportsOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research